Chi Yan

1.3k total citations
43 papers, 805 citations indexed

About

Chi Yan is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Chi Yan has authored 43 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 17 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Chi Yan's work include Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (7 papers) and CAR-T cell therapy research (6 papers). Chi Yan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (7 papers) and CAR-T cell therapy research (6 papers). Chi Yan collaborates with scholars based in United States, China and Canada. Chi Yan's co-authors include Ann Richmond, Genlou Sun, Sheau‐Chiann Chen, Jinming Yang, Anna E. Vilgelm, Gregory D. Ayers, Christopher Andrew Johnson, Nabil Saleh, Dongfa Sun and Oliver D. King and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Chi Yan

40 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chi Yan United States	18	385	310	199	132	108	43	805
Boris Shor United States	14	946 2.5×	272 0.9×	151 0.8×	88 0.7×	85 0.8×	16	1.3k
Craig C. Whiteford United States	15	563 1.5×	164 0.5×	107 0.5×	75 0.6×	175 1.6×	16	899
Christopher L. Neal United States	12	857 2.2×	376 1.2×	106 0.5×	50 0.4×	124 1.1×	18	1.1k
Sumaiyah K. Rehman United States	8	740 1.9×	386 1.2×	37 0.2×	72 0.5×	420 3.9×	12	1.1k
Marie-Ève Beaulieu Spain	15	782 2.0×	265 0.9×	98 0.5×	59 0.4×	156 1.4×	29	1.1k
Zee‐Fen Chang Taiwan	17	553 1.4×	144 0.5×	130 0.7×	33 0.3×	83 0.8×	26	857
Simone Weidlich United Kingdom	18	1.1k 2.8×	352 1.1×	86 0.4×	51 0.4×	203 1.9×	19	1.2k
Lior Golomb Israel	11	726 1.9×	242 0.8×	89 0.4×	61 0.5×	89 0.8×	14	924
Lőrinc Sándor Pongor United States	19	851 2.2×	387 1.2×	113 0.6×	161 1.2×	374 3.5×	54	1.3k
Inken Wierstra Germany	13	989 2.6×	205 0.7×	92 0.5×	58 0.4×	184 1.7×	15	1.2k

Countries citing papers authored by Chi Yan

Since Specialization

Citations

This map shows the geographic impact of Chi Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Yan more than expected).

Fields of papers citing papers by Chi Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Yan. The network helps show where Chi Yan may publish in the future.

Co-authorship network of co-authors of Chi Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Chi Yan. A scholar is included among the top collaborators of Chi Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi Yan. Chi Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Jiuzhou, et al.. (2025). HLA-I genotype landscape in lung cancer and its prognosis value in Chinese small cell lung cancer. Scientific Reports. 15(1). 33691–33691.

Li, Xiaojiao, Wenxuan Chen, Zihao Wang, et al.. (2025). Sustainable postharvest management practices for kiwifruit: Principles, approaches, and future directions. Postharvest Biology and Technology. 233. 114008–114008.

Zhang, Siwen, Yujun Li, Jialu Liu, et al.. (2024). Evaluation of large language models under different training background in Chinese medical examination: a comparative study. Frontiers in Artificial Intelligence. 7. 1442975–1442975. 2 indexed citations

Shattuck-Brandt, Rebecca L., Carly Bess Scalise, Sheau‐Chiann Chen, et al.. (2024). Endogenous pAKT activity is associated with response to AKT inhibition alone and in combination with immune checkpoint inhibition in murine models of TNBC. Cancer Letters. 586. 216681–216681. 5 indexed citations

Yan, Chi, Caroline A. Nebhan, Nabil Saleh, et al.. (2023). Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma. Cancers. 15(14). 3695–3695. 5 indexed citations

Ngwa, Verra M., Deanna N. Edwards, Yoonha Hwang, et al.. (2022). Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy. Cancer Research Communications. 2(7). 694–705. 5 indexed citations

Richmond, Ann, et al.. (2022). Immunomodulatory Properties of PI3K/AKT/mTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 23(13). 7353–7353. 50 indexed citations

Yan, Chi, Sheau‐Chiann Chen, Gregory D. Ayers, et al.. (2022). Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients. npj Precision Oncology. 6(1). 6–6. 7 indexed citations

Yan, Chi, Jinming Yang, Nabil Saleh, et al.. (2021). Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer. International Journal of Molecular Sciences. 22(10). 5207–5207. 38 indexed citations

10.

Yan, Chi & Ann Richmond. (2021). Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy. Molecular Cancer. 20(1). 146–146. 34 indexed citations

11.

Xing, Wenqun, Haibo Sun, Chi Yan, et al.. (2021). A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules. BMC Cancer. 21(1). 263–263. 20 indexed citations

12.

Yan, Chi, Nabil Saleh, Jinming Yang, et al.. (2021). Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Molecular Cancer. 20(1). 85–85. 28 indexed citations

13.

Scalise, Carly Bess, Caroline A. Nebhan, Jinming Yang, et al.. (2020). Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy. Breast Cancer Research and Treatment. 184(2). 357–364. 6 indexed citations

14.

Shattuck-Brandt, Rebecca L., Sheau‐Chiann Chen, Emily Murray, et al.. (2020). Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition. Clinical Cancer Research. 26(14). 3803–3818. 22 indexed citations

15.

Yang, Jinming, Chi Yan, Anna E. Vilgelm, et al.. (2020). Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity. Cancer Immunology Research. 9(2). 200–213. 56 indexed citations

16.

Liu, Jinghua, Simon Gebremeskel, Chi Yan, et al.. (2020). Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas. Scientific Reports. 10(1). 13343–13343. 26 indexed citations

17.

Tan, Zhiwu, Chi Yan, Yik Chun Wong, et al.. (2020). Antimesothelioma Immunotherapy by CTLA-4 Blockade Depends on Active PD1-Based TWIST1 Vaccination. Molecular Therapy — Oncolytics. 16. 302–317. 10 indexed citations

18.

Vilgelm, Anna E., Nabil Saleh, Rebecca L. Shattuck-Brandt, et al.. (2019). MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21. Science Translational Medicine. 11(505). 88 indexed citations

19.

Yan, Chi. (2013). EXPRESSION AND FUNCTION ANALYSIS OF Akt/PKB IN PATHOGENS-CHALLENGED CHINESE SHRIMP FENNEROPENAEUS CHINENSIS. Haiyang yu huzhao. 6 indexed citations

20.

Yan, Chi. (2007). Dynamic Changes of Endogenous Hormones Contents in Mutant of Populus tomentosaand and its Relative Species in the Cutting and Rooting Procedure. Anhui nongye kexue. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact